Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07728279 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Respiratory Muscle Training on Cognition in Older Adults

StatusEnrolling by Invitation
PhaseNot applicable
Started2026-07-24
View on ClinicalTrials.gov ↗

Amendment history

2026-07-27
minor
Study Status, Outcome Measures, Contacts/Locations v1
Secondary endpointsdetails revised at 3 of 3 entries
Study sitesdetails revised at 1 of 1 site
2026-07-22
minor
Original filing
The increase in chronic diseases associated with aging leads to various physical limitations in older adults, negatively impacting fall risk, hospitalization rates, and overall mortality. While Inspiratory Muscle Training (IMT) is frequently utilized in rehabilitation programs due to its low cost and ease of use to enhance respiratory muscle strength, balance, and functional capacity, its potential effects on cognitive function remain unexamined. The primary objective of this pilot randomized controlled trial is to investigate the effect of an 8-week Inspiratory Muscle Training (IMT) program on cognitive function in older adults. A secondary objective is to examine the relationship between cardiovascular risk factors and respiratory muscle strength in this population. Researchers hypothesize that an 8-week IMT intervention will have a significant effect on cognitive function in older adults compared to a control group. To test this hypothesis, a total of 24 eligible older adults will be randomly assigned to either perform daily breathing exercises using an external device for 8 weeks or maintain their routine daily activities. Both groups will be assessed at baseline and after the 8-week period to evaluate changes in cognitive, functional, and physical parameters.
Trial Details
NCT Number NCT07728279
Lead Sponsor Acibadem University
Conditions Older Adults
Enrollment 24 participants
Start Date 2026-07-24
Primary Completion 2026-11-20 (estimated)
Study Completion 2027-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-28